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http://www.biomedcentral.com/1471-2164/14/92RESEARCH ARTICLE Open AccessCombined ChIP-Seq and transcriptome analysis
identifies AP-1/JunD as a primary regulator of
oxidative stress and IL-1β synthesis in
macrophages
Richard P Hull1, Prashant K Srivastava1, Zelpha D’Souza1, Santosh S Atanur1, Fatima Mechta-Grigoriou2,
Laurence Game1, Enrico Petretto1, H Terence Cook3, Timothy J Aitman1 and Jacques Behmoaras3*Abstract
Background: The oxidative burst is one of the major antimicrobial mechanisms adopted by macrophages. The
WKY rat strain is uniquely susceptible to experimentally induced macrophage-dependent crescentic
glomerulonephritis (Crgn). We previously identified the AP-1 transcription factor JunD as a determinant of
macrophage activation in WKY bone marrow-derived macrophages (BMDMs). JunD is over-expressed in WKY
BMDMs and its silencing reduces Fc receptor-mediated oxidative burst in these cells.
Results: Here we combined Jund RNA interference with microarray analyses alongside ChIP-sequencing (ChIP-Seq)
analyses in WKY BMDMs to investigate JunD-mediated control of macrophage activation in basal and
lipopolysaccharide (LPS) stimulated cells. Microarray analysis following Jund silencing showed that Jund activates
and represses gene expression with marked differential expression (>3 fold) for genes linked with oxidative stress
and IL-1β expression. These results were complemented by comparing whole genome expression in WKY BMDMs
with Jund congenic strain (WKY.LCrgn2) BMDMs which express lower levels of JunD. ChIP-Seq analyses
demonstrated that the increased expression of JunD resulted in an increased number of binding events in WKY
BMDMs compared to WKY.LCrgn2 BMDMs. Combined ChIP-Seq and microarray analysis revealed a set of primary
JunD-targets through which JunD exerts its effect on oxidative stress and IL-1β synthesis in basal and
LPS-stimulated macrophages.
Conclusions: These findings demonstrate how genetically determined levels of a transcription factor affect its
binding sites in primary cells and identify JunD as a key regulator of oxidative stress and IL-1β synthesis in primary
macrophages, which may play a role in susceptibility to Crgn.Background
Macrophages are efficient phagocytes of the immune
system that produce reactive oxygen species (ROS) dur-
ing the phagocytosis of pathogens, considered as a mar-
ker of cell activation. The well-established classical
pathway of macrophage activation induced by interferon
(IFN)-γ and/or lipopolysaccharide (LPS) is known to
play a vital role in host defence during inflammation.
Macrophages activated in this manner express high* Correspondence: jacques.behmoaras@imperial.ac.uk
3Centre of Complement and Inflammation Research, Imperial College
London, Du Cane Road W12 0NN, London, UK
Full list of author information is available at the end of the article
© 2013 Hull et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orlevels of proinflammatory cytokines and reactive oxygen
and nitrogen intermediates that are crucial in the de-
fence against intracellular pathogens [1,2]. The AP-1
transcription factor plays a key role in regulating cell
growth and environmental stress responses [3-5]. In
classically activated (M1) macrophages, AP-1 plays a
central role together with NF-κB in signal-dependant
gene expression that is crucial for innate immunity [6].
JunD is a member of AP-1 that is constitutively
expressed and has been previously shown to protect cells
from oxidative stress and to reduce tumour angiogenesis
by limiting the production of ROS [7]. The chronic oxi-
dative stress generated by the inactivation of JunD, has. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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velopment [8,9]. In various tissues, including the kidney,
the absence of JunD led to the over-expression of hyp-
oxia inducible factor (HIF)-target genes in podocytes,
most likely as a result of increased oxidative stress [10].
Wistar Kyoto (WKY) rats are uniquely susceptible to
nephrotoxic nephritis (NTN), a rat model of crescentic
glomerulonephritis (Crgn) [11]. The macrophages of this
strain show a 20-fold increase in Jund mRNA expression
as well as increased specific JunD protein binding to AP-
1 consensus sequence nucleotides (50-TGAGTCA-30)
when compared with the NTN-resistant LEW strain
[12]. In addition WKY BMDMs show greater superoxide
anion production when stimulated with PMA (unpub-
lished observations) and significantly increased NOS2
expression [13] when stimulated with LPS, suggesting
that the macrophages of this strain have a genetically
determined pro-inflammatory phenotype characterised
by increased oxidative stress. We have previously shown
that JunD is a determinant of the macrophage oxidative
burst associated with crescentic glomerulonephritis. In a
genome-wide linkage analysis and haplotype analysis for
NTN-related phenotypes in WKY and LEW rats, we
delineated a minimal genomic region of 130 kb on rat
chromosome 16 where Jund was the only markedly
over-expressed transcript. The functional role of JunD
was established by siRNA knock-down of Jund in WKY
BMDMs [12] which resulted in reduced Fc receptor
mediated oxidative burst confirming the previously
reported antioxidant role of JunD in other tissues [7,9].
Furthermore, the role of JunD in TLR4-induced primary
human macrophage activation was established. siRNA
knockdown of JUND in these cells resulted in a signifi-
cantly reduced secretion of TNFα, IL-6 and IL-10 [12].
One possible mechanism for this was suggested by Smo-
linska and colleagues who showed that Hck kinase med-
iates TLR4-induced transcription of both TNF and IL-6
through binding of AP-1 heterodimers composed of c-
Fos and JunD [14]. Based on these results, we hypothe-
sised that JunD controls respiratory burst and the related
oxidative stress in basal and classically activated (LPS/
TLR4, M1) macrophages.
To identify genes and pathways regulated by JunD-
mediated macrophage activation in WKY BMDMs, we
have carried out microarray-based gene expression stud-
ies following siRNA knock down of Jund in basal and
LPS-stimulated conditions. ChIP-Seq analysis was per-
formed on basal and LPS-stimulated WKY BMDMs and
used to complement the microarray results in order to
identify primary JunD targets. ChIP-Seq and microarray
analyses were also carried out in a Jund congenic strain
(WKY.LCrgn2) known to have reduced JunD mRNA and
protein levels [12]. In this strain, the Jund locus was
transferred from the Lewis strain into the WKY strain byback-crossing over nine generations. Genome-wide inte-
gration of all datasets identified primary JunD-target
genes and a regulatory network involved in oxidative
stress and IL-1β expression in macrophages leading to
increases in mature IL-1β production in BMDMs and
glomeruli from the WKY strain.
Results
Jund regulates macrophage gene expression that controls
primarily oxidative stress and IL-1β synthesis
A description of the macrophage function related to dif-
ferent levels of JunD expression in different inbred rat is
summarised in Table 1. In order to identify genes under
the transcriptional control of JunD in primary macro-
phages, expression levels of Jund were first silenced by
RNA interference in the WKY BMDMs that over-
express JunD (Figure 1) [12]. Following confirmation of
knockdown by qRT-PCR and Western blot (Figure 2A
and C), the samples were subjected to microarray ana-
lysis (Additional file 1: Figure S1A). Because AP1/JunD
regulates lipopolysaccharide (LPS)-TLR4 mediated cyto-
kine secretion in primary human macrophages [12,14],
microarray analysis was also performed in samples trea-
ted with Jund siRNA (48h) and stimulated with LPS for
8 h (Figure 2B and Additional file 1: Figure S1B).
Genome-wide analysis of the BMDM transcriptome
identified 1672 differentially expressed genes between
unstimulated BMDMs transfected with Jund siRNA
compared to scrambled control and 1,476 differentially
expressed genes following 8 hours of LPS (100ng/ml)
stimulation (FDR< 5%). JunD acted both as an activator
and as a repressor of gene expression in BMDMs. Trans-
fection of WKY BMDMs with Jund siRNA, thereby low-
ering Jund expression, resulted in the reduced
expression of 868 genes out of 1672 (~ 50%) demon-
strating that Jund had an activatory role in gene tran-
scription. Alongside this, Jund knockdown also
increased the expression of 804 genes (~ 50%) demon-
strating that Jund could also have a repressive effect on
transcription. After eight hours of LPS stimulation, 638
genes had reduced expression in the Jund siRNA knock-
down group compared to controls and 838 genes
demonstrated higher expression following Jund knock-
down. Validation by qRT-PCR of a set of differentially
expressed genes following Jund siRNA knock-down that
encompassed a range of fold change differences between
the two siRNA groups confirmed the microarray find-
ings (Figure 3A and B, Additional file 2: Table S1) in 21
out of the 23 (91%) genes selected. The directional
change (activation or repression) of the microarray data
was confirmed in all 23 genes.
Amongst the genes showing the most marked expres-
sion changes following Jund siRNA knock-down in
WKY BMDMs, 11 genes were found to have greater
Table 1 JunD levels and macrophage oxidative burst in rat strains used for the combined ChIP-Seq and transcriptome
approach
Strain JunD levels in macrophages* Macrophage activation **
WKY +++ +++
WKY.LCrgn2 + +
Lewis + +
* Jund expression levels and JunD/AP-1 protein binding measured by qRT-PCR and TransAm assay [12].
** Macrophage activation assessed by Fc receptor mediated oxidative burst [12].
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siRNA groups (scrambled vs. Jund siRNA) in the un-
stimulated state and 2 genes were identified in the LPS
stimulated state (Table 2). Interestingly, the individual
functions of the majority of these genes belong to two
main categories: oxidative stress (Mt2a [15], Lcn2 [16],
Vcan [17], Hspb1 [18], Prkca [19]) and IL-1β synthesis
(Klrb1a [20], Il1b, Nlrp3 [21]). This suggests that JunD
has a primary role in regulating macrophage gene
expression associated with oxidative stress and IL-1β
synthesis. To investigate this further, we performed
genome-wide expression analysis by microarrays over an
eight hour time course of LPS stimulation in WKY and
WKY.LCrgn2 BMDMs (Additional file 1: Figure S1C).
The latter is a Jund congenic strain generated by intro-
gression of the Jund locus on chromosome 16 from the
Lewis donor onto the WKY recipient genome. WKY.
LCrgn2 rats have significantly less Jund mRNA and JunD
protein levels in their BMDMs when compared with par-
ental WKY BMDMs (Table 1). The microarray results
between the WKY and WKY.LCrgn2 BMDMs identified
that 830 genes were differentially expressed over theFigure 1 Strategy employed to identify primary JunD targets in
bone marrow derived macrophages. We performed Jund RNAi
and compared whole genome expression profiling in macrophages
(basal and stimulated with LPS, 100ng/ml, 8h) transfected with
scrambled siRNA to those transfected with Jund siRNA. ChIP-Seq
analysis was performed in WKY and WKY.LCrgn2 BMDMs (basal and
stimulated with LPS, 100ng/ml, 2h). Transcripts showing a fold
change > 3 in the RNAi dataset were examined for JunD/AP1 peaks.eight hour timecourse. They were functionally associated
with multiple immune terms focused on responses
to stimuli including LPS and the regulation of cell
activation (Table 3) and were validated by qRT-PCR
(Additional file 1: Figure S2). A set of 201 genes that
were common with the Jund siRNA knockdown was
identified. Amongst these, seven transcripts showed a
fold change greater than 2 (FDR < 5%) including metal-
lothionein 2A (Mt2a), arginase (Arg1) and cysteine diox-
ygenase, type 1 (Cdo1), genes associated with oxidative
stress. The significant differential expression of these
transcripts together with Jund between WKY and
WKY.LCrgn2 BMDMs was confirmed by qRT-PCR
(Figure 3C-F). Taken together the combined RNAi and
congenic whole genome differential expression analysis
identifies genes primarily regulating oxidative stress and
IL-1β synthesis under transcriptional control of JunD.
JunD expression levels determine the extent of the JunD
cistromes
We next combined our microarray approaches investi-
gating JunD-mediated transcriptional control of genes
with a cistrome analysis of JunD between basal and two
hour LPS stimulated WKY and WKY.LCrgn2 BMDMs
using ChIP-Seq (Figure 1). The aligned sequencing
reads (Additional file 2: Table S2) were analysed using
BayesPeak [22,23] in order to identify areas of sequen-
cing enrichment that signified JunD-binding events,
termed peaks. This analysis identified a greater number
of peaks in WKY basal and LPS-stimulated BMDMs
compared to WKY.LCrgn2 BMDMs in both conditions
(Table 4). Peaks were linked to a gene if they were
located within 20 kilobases of the transcriptional start
site or were located within the gene body. This meant
that genetically determined differences in JunD levels
resulted in an almost 50% reduction in the number of
ChIP-Seq peaks that were linked to a protein coding
gene in the basal state and an 87% reduction after LPS
stimulation (Table 4). Fourteen peaks were successfully
validated by ChIP-qPCR in WKY BMDMs with all the
peaks showing at least two-fold enrichment for JunD
above background (Additional file 1: Figure S3A and
S3B). The reduced level of JunD expression in the
WKY.LCrgn2 strain was reflected in the lower
levels of enrichment for the seven peaks analysed
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Figure 2 siRNA mediated knockdown of Jund. Assessment of the efficiency of siRNA knockdown of Jund in the unstimulated state (A, C) and
following eight hours LPS stimulation (B) using qRT-PCR and Western blotting. siRNA experiments were performed in 4 different WKY rats in
triplicate. ***P<0.001 using two tailed unpaired t-test to compare BMDMs transfected for 48 hours with either scrambled control siRNA or Jund
siRNA. The Western blot (C) for JunD is representative of four different Jund silencing experiments in WKY BMDMs and is demonstrated alongside
β-actin loading control.
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ChIP-Seq peaks in all the strains were located in
intergenic regions (35-44% across the datasets) whilst
the WKY BMDMs had a higher proportion of JunD
peaks within the body of the gene (exon or intron)
compared to WKY.LCrgn2 BMDMs in both the un-
stimulated and LPS stimulated states (Figure 4A).
The distance from the nearest gene to each peak
was calculated and peaks were found to be preferen-
tially located close to the TSS in both strains
(Figure 4B). De novo motif discovery using HOMER
identified a 12 base pair motif in 63% of peaks in
WKY LPS stimulated BMDMs with a strong similarity to
the consensus AP-1 motif that has been previously recog-
nised and shown to be functionally active [24] (Figure 4C).
Additional motifs identified included CAC binding and
REST/NRSF in basal WKY BMDMs (Figure 4D) and the
Ascl2, CACCC binding motif for KLF factors, Eomes and
Ets (Figure 4E) in LPS stimulated WKY BMDMs. Further-
more the JunD binding to the promoters of Il1b and Prkca,two of the most markedly differentially expressed
transcripts following Jund siRNA were confirmed by ChIP-
qPCR in both the basal and LPS stimulated conditions
(Figure 4F, Additional file 1: Figure S4)
Gene ontology analysis of the JunD-bound genes in
the different strains and states identified marked similar-
ities between the enriched terms in basal WKY BMDMs
(Additional file 2: Table S3) and WKY.LCrgn2 BMDMs
(Additional file 2: Table S4) as well as LPS stimulated
WKY.LCrgn2 BMDMs (Additional file 2: Table S5)
covering multiple autoimmune disease pathways and
core macrophage functions such as antigen processing.
This suggested that regardless of expression level, JunD
binds to genes involved in core macrophage processes.
Following LPS stimulation in WKY BMDMs enrichment
was seen for immune processes linked with the response
of the macrophage to stimulation such as intracellular
signalling cascades and the MAPK signalling pathway
(Additional file 2: Table S6) highlighting the role played
by JunD in the LPS response.
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Figure 3 Validation of microarray results confirms that JunD has both activatory and repressive roles in controlling gene expression
linked with oxidative stress. Validation of differentially expressed genes were carried out using four biological replicates with three technical
amplification replicates per siRNA type for the unstimulated (A) and eight hour LPS stimulated (B) data sets. Relative gene expression was
normalised to Hprt and used to generate fold change values. *P<0.05; **P<0.01;***P<0.001 using a two-tailed unpaired t-test to detect statistically
significant differences between the siRNA groups. Error bars represent standard error of the mean. Confirmation of the differential expression of
Jund between WKY and WKY.LCrgn2 BMDMs (C) and key JunD targets; Arg1 (D), Cdo1 (E) and Mt2a (F), influenced by Jund siRNA knockdown with
>2 fold change in expression that were also differentially expressed between WKY and WKY.LCrgn2 BMDMs over a timecourse of LPS stimulation.
Samples from the WKY and WKY.LCrgn2 strains were amplified using a set of four biological replicates with three technical replicates per sample.
***P<0.001 statistically significantly different to WKY using a two way ANOVA to compare the overall timecourse with Bonferonni’s post-tests to
compare individual time points.
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primary JunD targets in macrophages
In order to identify the set of primary JunD targets, we
integrated all the genomic datasets and identified the
genes that correlated closely with the expression pattern
of Jund during the LPS timecourse that were also differ-
entially expressed following siRNA knockdown of Jund
and showed a ChIP-Seq peak in WKY BMDMs. This
identified two major networks (basal and LPS) with 24
genes in the basal state (Figure 5, upper panel) and 36
genes after LPS stimulation (Figure 5, lower panel) as
primary JunD targets through which JunD mediates its
effect on macrophage activation. The primary JunD
targets correlate with Jund expression levels in two inde-
pendent datasets (microarray analysis on WKY and
WKY.LCrgn2 BMDM LPS time course and microarray
on Jund siRNA in WKY BMDMs) and have a JunD
ChIP-Seq peak in WKY BMDMs. These are genes whereTable 2 Microarray results of transcripts demonstrating great
siRNA and scrambled control siRNA transfected WKY BMDMs
Gene symbol Gene name
Basal condition
Klrb1a killer cell lectin-like receptor subfamily B member 1B
Mt2A metallothionein 2A
Il1b interleukin 1 beta
Cxcl9 chemokine (C-X-C motif) ligand 9
Lcn2 lipocalin 2
Vcan versican
Nlrp3 NLR family, pyrin domain containing 3
D3ZIY9_RAT uncharacterised protein
Dot1l DOT1-like, histone H3 methyltransferase (S. cerevisiae)
Hspb1 heat shock protein 1
Prkca protein kinase C, alpha
LPS stimulated condition
Klrb1a killer cell lectin-like receptor subfamily B member 1B
Hspb1 heat shock protein 1
Differentially expressed transcripts with greater than three-fold difference in expres
threshold following 40,000 permutations. Fold changes are of control siRNA versus
BMDMs transfected with scrambled control siRNA i.e. with a higher level of Jund ex
discovery rate.the expression is under direct control of JunD/AP1
binding, correlating with cellular JunD levels. The tran-
scription factor Runx1 was identified as primary Jund
targets together with several genes involved in oxidative
stress such as Trpv4, Vav2, Ifi30, Nqo2, and P2ry2,
Ctnnb1 and Bcl2l1 Additional file 1: Figure S5).
JunD expression levels determine active IL-1β secretion in
primary macrophages and nephritic glomeruli
Since the previous role of JunD is regulating macrophage
oxidative burst is known [12] and our data shows that
JunD regulates genes involved in IL-1β synthesis (Il1b,
Nlrp3, Klrb1a), we investigated whether JunD regulates
active IL-1β secretion following Nlrp3-inflammasome
activation in primary rat macrophages. Western Blot
analysis of mature IL-1β in BMDMs primed with LPS
and activated by ATP demonstrated a reduction in ma-
ture IL-1β between WKY and WKY.LCrgn2 BMDMser than three-fold difference in expression between Jund
Chr. Fold change FDR (%) Gene Function
4 9.0 <0.01 IL-1β synthesis [19]
19 4.6 0.63 Oxidative stress [15]
3 4.1 2.85 IL-1β synthesis
14 3.5 <0.01 Inflammation
3 3.3 <0.01 Oxidative stress [16]
2 3.3 <0.01 Oxidative stress [17]
10 3.2 3.01 IL-1β synthesis [21]
10 3.1 1.09 -
7 −3.7 2.30 Inflammation
12 −3.8 <0.01 Oxidative stress [18]
10 −4.1 1.83 Oxidative stress [19]
4 4.6 <0.01 IL-1β synthesis [20]
12 −4.0 <0.01 Oxidative stress [18]
sion (four technical replicates per strain) were identified at a <5% FDR
Jund siRNA expression. A positive fold change indicates higher expression in
pression compared to Jund siRNA. Abbreviations: Chr.; chromosome, FDR: false
Table 3 Gene ontology analysis for genes demonstrating differential expression over the eight hour LPS timecourse
between WKY and WKY.LCrgn2 BMDMs
Gene ontology term (BP_FAT or KEGG pathway) Genes (n) Fold Enrichment Bonferroni corrected P-Value
GO:0010033~response to organic substance 84 2.23 9.00E-09
GO:0009725~response to hormone stimulus 53 2.57 1.59E-06
GO:0009611~response to wounding 46 2.68 6.71E-06
GO:0009719~response to endogenous stimulus 53 2.28 9.90E-05
GO:0001775~cell activation 31 3.18 1.08E-04
GO:0043434~response to peptide hormone stimulus 29 3.24 2.22E-04
GO:0050865~regulation of cell activation 25 3.63 2.44E-04
GO:0002237~response to molecule of bacterial origin 21 4.02 6.34E-04
GO:0002694~regulation of leukocyte activation 23 3.49 0.0018
GO:0032496~response to lipopolysaccharide 19 3.95 0.0036
GO:0045767~regulation of anti-apoptosis 11 7.37 0.0039
GO:0045321~leukocyte activation 26 3.04 0.0039
GO:0001817~regulation of cytokine production 22 3.42 0.0047
GO:0009617~response to bacterium 26 3.00 0.0052
GO:0006954~inflammatory response 26 2.98 0.0056
GO:0048545~response to steroid hormone stimulus 31 2.65 0.0058
GO:0043067~regulation of programmed cell death 54 1.96 0.0079
GO:0010941~regulation of cell death 54 1.96 0.0085
GO:0031667~response to nutrient levels 30 2.64 0.0095
GO:0042981~regulation of apoptosis 53 1.95 0.012
GO:0009991~response to extracellular stimulus 31 2.54 0.014
GO:0002684~positive regulation of immune system process 26 2.80 0.018
GO:0051249~regulation of lymphocyte activation 20 3.37 0.020
GO:0007568~aging 20 3.35 0.022
GO:0006952~defense response 36 2.28 0.024
GO:0045768~positive regulation of anti-apoptosis 9 8.03 0.027
GO:0007565~female pregnancy 16 3.94 0.033
GO:0014070~response to organic cyclic substance 24 2.85 0.033
GO:0008283~cell proliferation 27 2.62 0.036
GO:0046649~lymphocyte activation 21 3.09 0.041
GO:0042592~homeostatic process 53 1.86 0.044
Enrichment for biological process functional annotation terms and KEGG canonical pathways used a Bonferroni corrected p-value threshold of <0.05.
Abbreviations: BP_FAT, subset of Biological Process Gene Ontology (GO) terms generated by DAVID; n, number of involved genes.
Table 4 JunD binding events in WKY and WKY.LCrgn2 BMDMs
Dataset Total number of
peaks identified
Number of peaks
linked to a gene
Number of genes containing
at least one JunD peak
WKY basal 27124 12522 5339
WKY LPS 36687 18124 7612
WKY.LCrgn2 basal 16593 6408 2606
WKY.LCrgn2 LPS 8689 3361 1022
Peaks were identified using BayesPeak v1.1.3 [22,23] using a posterior probability threshold of 0.9. Peaks were linked to a gene if they were located within 20
kilobases of the transcriptional start site or were located within the body of the gene.
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Figure 4 (See legend on next page.)
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Figure 4 Genetically determined differences in Jund expression alter the JunD cistrome and identifies primary JunD targets. (A)
Distribution of JunD-peaks relative to transcriptional start sites (TSS) of Ensembl genes. Promoter region defined as 20 kilobases (kb) upstream of
the TSS, upstream region between 10kb and 50kb upstream from TSS. (B) Occurrence of peaks within 100 kilobases of the TSS. (C) Twelve base
pair AP-1 motif identified by de novo motif analysis present in 63% peaks. De novo motif analysis using HOMER identified two de novo motifs in
basal WKY BMDMs (D) and four motifs in LPS stimulated WKY BMDMs (E). The de novo motif identified is displayed on the bottom of each the
pair of motifs, the matched consensus motif for a transcription factor on the top. (F) Il1b and Prkca confirmed as primary JunD targets by qPCR
validation. The aligned reads comprising peak passing the posterior probability threshold of 0.9 for each JunD-bound gene in the WKY strain in
the LPS stimulated state for l1b and the basal state for Prkca are shown in genome browser views along with the peak in the WKY.LCrgn2 strain.
Samples from WKY and WKY.LCrgn2 strains were amplified using three biological replicates with three technical replicates per sample. Results
expressed as mean fold change over IgG. *P<0.05; **P<0.01; using a one-tailed unpaired t-test to detect statistically significant differences
between the strain and condition pairs. Error bars represent standard error of the mean.
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http://www.biomedcentral.com/1471-2164/14/92(Figure 6A). Importantly, there was a marked increase in
mature IL-1β production in LEW.WCrgn2 BMDMs com-
pared to LEW confirming that the Jund congenic interval
was able to alter mature IL-1β production (Figure 6A).
These results were confirmed by ELISA for IL-1β in LPS
primed and ATP stimulated BMDMs which showed
significant differences between the production of IL-1β
by WKY BMDMs compared to WKY.LCrgn2 and LEW
BMDMs (Figure 6B). The production of IL-1β in neph-
ritic glomeruli from WKY, WKY.LCrgn2, LEW and LEW.
WCrgn2 rats was examined (Figure 6C). This showed a
significant reduction in IL-1β production in all the other
strains compared to WKY demonstrating a role for the
Crgn2 congenic interval in IL-1β production.
Discussion
The aim of the present study was to investigate genes
regulated by JunD mediating macrophage oxidative burst
and pro-inflammatory cytokine production leading to
enhanced cell activation in the WKY rat. We used com-
bined microarray and JunD/AP1 ChIP-Seq analyses in
primary BMDMs from WKY (NTN-susceptible, high
JunD levels, enhanced macrophage oxidative burst) and
congenic WKY.LCrgn2 (reduced NTN, reduced JunD
levels, reduced macrophage oxidative burst) rats. Micro-
array analysis was performed in two experimental settings:
following Jund siRNA knockdown using lipid-based trans-
fection in WKY BMDMs and between WKY and WKY.
LCrgn2 primary macrophages. ChIP-Seq analysis was also
performed between WKY and WKY.LCrgn2 BMDMs in
order to identify primary JunD targets. Microarray and
ChIP-Seq experiments were also performed in macro-
phages activated with LPS to assess the role of JunD in
macrophages activated through LPS/TLR4.
JunD reduces tumour angiogenesis by limiting Ras-
mediated production of reactive oxygen species (ROS)
implicated in the pathophysiology of various diseases, in-
cluding cancer , regulates genes involved in antioxidant
defence and enhances the transcription of VEGF-A, a
potent proangiogenic factor [7,9]. In addition JunD defi-
cient mice display persistent hyperinsulinaemia resulting
from enhanced pancreatic islet vascularization owing tochronic oxidative stress [9]. In crescentic glomerulo-
nephritis JunD deficiency may cause increased oxidative
stress in the glomerular podocytes, leading to altered
VEGFA expression and subsequent glomerular injury
[10]. In the rat NTN model of Crgn, reduced JunD ex-
pression in the congenic WKY.LCrgn2 strain is asso-
ciated with 11% reduction in glomerular crescent
formation [12,13]. We have carried out a combined
ChIP-Seq and transcriptome approach in macrophages,
the main effector cells of Crgn, in order to identify JunD
targets that may explain its modulatory role. Alongside a
general effect by JunD to alter the immune response to
LPS in the overall gene sets, the functions of strongly
dysregulated (>3 fold) expression changes suggested that
primary gene targets of JunD are key effectors in mediat-
ing protection from oxidative stress and IL-1β synthesis.
Interestingly, this approach identified genes regulating
oxidative stress that were previously identified to be
under the regulation of JunD in fibroblasts (i.e. cysteine
dioxygenase [7]) suggesting that JunD may have com-
mon targets in the oxidative stress pathway in different
cell types. JunD regulates IL-1β secretion in rat BMDMs
and pro-inflammatory cytokine secretion in human
monocyte-derived macrophages [12] suggesting that
its role of the regulation of the M1 macrophage activa-
tion is conserved across the species. Taken together
these observations suggest that JunD regulates oxidative
stress various diseases with both common and cell spe-
cific targets.
Current understanding of JunD function on a genome
wide scale has been limited by studies performed on a
candidate gene or promoter basis [24-26]. The Encyclo-
paedia of DNA elements (ENCODE) project has carried
out ChIP-Seq for JunD in human transformed cell lines
though not in a macrophage or monocyte cell lines [27-29].
JunD has been categorised as a middle-level transcrip-
tion factor and such factors regulate information-flow
bottlenecks and may be the best therapeutic targets
for strongly affecting the flow of information through
regulatory circuits [29]. The cistrome of JunD was also
found to be highly context and cell type specific [29,30].
We used primary macrophages from two inbred rat
Primary JunD-targets
Basal state
LPS-stimulated state
>1.3
<-1.3
Fold Change
-1.3
1.3
Down-regulated
after Jund siRNA
Up-regulated
after Jund siRNA
Primary JunD-targets
Down-regulated
after Jund siRNA
Up-regulated
after Jund siRNA
Figure 5 Integrative analysis identifies primary JunD targets in basal and LPS stimulated BMDMs. Jund gene expression patterns in WKY
and WKY.LCrgn2 BMDMs over the LPS time course were used for Spearman correlation analysis with the rest of the transcripts on the microarrays
(P < 0.001 cut off). The correlated genes were used for building the JunD target gene networks and selected based on i. significant differential
expression following Jund siRNA knockdown (both basal and after LPS stimulation FDR< 5%), ii. presence of the JunD ChIP-Seq peak in WKY
BMDMs (both basal and after LPS stimulation). The outer ring represents all the transcripts correlating with Jund expression levels (P<0.001) in
WKY and WKY.LCrgn2 BMDMs (1445 transcripts, 75%, indicated in grey circles) over the LPS time course. Transcripts associated with a JunD ChIP-
Seq peak (within 20kb of TSS or within the gene body) are shown as black circles (232 transcripts, 12%). The transcripts correlating with Jund
expression levels and down-regulated following Jund siRNA (basal, upper panel) are shown in blue (125 transcripts, 6.5%); and those up-regulated
(basal, upper panel) are shown as red circles (116 transcripts, 6%). Primary JunD targets in basal BMDMs are given with the gene names and
show a JunD ChIP-Seq peak (24 transcripts, basal state, upper panel). This analysis was repeated for the LPS-stimulated macrophages taking into
account JunD siRNA and ChIP-Seq datasets in LPS stimulated macrophages and identified 36 primary Jund targets (lower panel).
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parative ChIP-Seq analysis to identify the genomic
regions uniquely bound by JunD. The overall landscape
of JunD binding in the BMDMs from WKY and WKY.
LCrgn2 BMDMs was comparable to that of other tran-
scription factors studied in primary macrophagesstimulated by LPS [31,32]. We found that after LPS
stimulation in WKY BMDMs, there was enrichment for
genes involved in multiple immune processes linked
with responses to multiple different stimuli. In combin-
ation with the gene expression data, these findings sug-
gest that genetically determined up-regulation of JunD
A B
C
Figure 6 JunD expression levels control the production of mature IL-1β in BMDMs and nephritic glomeruli. (A) Western blot of mature
IL-1β expression in WKY, WKY.LCrgn2, LEW and LEW.WCrgn2 BMDMs primed with LPS and stimulated with ATP. The result of 3 independent
experiments is demonstrated alongside β-actin loading control. ELISAs for IL-1β in LPS primed and ATP activated BMDMs (B) and in nephritic
glomeruli (C). **P<0.01 statistically significantly different to WKY using a one way-ANOVA with Bonferonni’s post-tests.
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in the WKY strain.
De novo motif analysis identified additional transcription
factor motifs that were unique to the WKY strain suggesting
that the increased levels of JunD expression facilitated new
partnerships with other transcription factors that did not
occur in WKY.LCrgn2 BMDMs. Key findings included the
CACCC-binding domain which binds Krüppel-like family
(KLF) transcription factors and are regulators of signalling
following activation of macrophages [33-35] and the Ets-1
motif, a factor controlling the expression of cytokine and
chemokine genes in a wide variety of cells [36] in LPS sti-
mulated WKY BMDMS. In basal WKY BMDMS a REST-
NRSF motif was identified consistent with the functional
findings of neuron development and differentiation in
unique core JunD-bound genes in WKY BMDMS and po-
tential roles for JunD in excitoxic neuronal cell death and is-
chaemic injury [37,38].
The main goal of the study was to identify primary
JunD target genes responsible for the macrophage acti-
vation seen in Crgn-susceptible WKY rat. The siRNA
knockdown experiments identified that genes with the
greatest changes in expression were associated with
IL-1β synthesis. The transcriptional control of Il1b ex-
pression by JunD was further confirmed by investigating
IL-1β secretion upon inflammasome activation in the
WKY and reciprocal Jund congenic strain BMDMs and
nephritic glomeruli (WKY.LCrgn2 and LEW.WCrgn2).Our integrative analysis identified primary JunD targets
through which JunD could primarily regulate macro-
phage activation. In the basal state multiple targets have
links with oxidative stress including Trpv4 [39], Vav2
[40-42], Ifi30 [43], Nqo2 [44] and P2ry2 [45]. This was
also seen after LPS stimulation with transcripts such as
Ctnnb1 [46] and Bcl2l11 [47] highlighting the key role of
JunD in the regulation of oxidative stress in WKY
BMDMs. Moreover, the transcription factor Runx1
(a target in the LPS stimulation group) has been identi-
fied as a primary JunD target suggesting that novel
transcription factor interactions in macrophages may
underlie some JunD-mediated macrophage activation.
Conclusions
Taken together our data show that genetically deter-
mined differences in physiological levels of JunD affect
its genome-wide binding patterns in basal and LPS-
stimulated primary macrophages. These results identi-
fied transcriptional programs underlying JunD-mediated
oxidative stress and IL-1β synthesis in primary macro-
phages which may play a role in susceptibility to Crgn.
Methods
Animals
WKY (WKY/NCrl) and LEW (LEW/Crl) rats were pur-
chased from Charles River (Margate, UK). Single con-
genic rats were generated by introgressing the Crgn2
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WKY recipient background and vice versa as previously
described [12]. All procedures were performed in ac-
cordance with the United Kingdom Animals (Scientific
Procedures) Act.
BMDM culture
BMDMs were prepared from the femurs of parental and
congenic strains using previously described methods
[12]. Femurs from adult (8-10 weeks) rats were isolated
and flushed with Hanks buffer (Life Technologies). Total
bone marrow derived cells were plated and cultured for
5 days in Dulbecco’s modified Eagle’s medium (Life
Technologies) containing 25 mM Hepes (Sigma), 25%
L929 conditioned medium, 25% decomplemented fetal
bovine serum (Biosera), penicillin (100 U/ml, Invitro-
gen), streptomycin (100 μg/ml, Invitrogen) and L-glu-
tamine (2 mM Invitrogen). The cells were characterised
as macrophages by ED-1 staining. Basal macrophages
were left unstimulated whilst stimulated cells were sti-
mulated with 100 ng/ml lipopolysaccharide (Sigma). Fol-
lowing stimulation, cells for gene expression analysis
were homogenized in TRIzol (Invitrogen) and stored at
-80°C.
siRNA inhibition of Jund expression
siRNA knockdown was carried out as previously
described [12]. Briefly, on day 5 of culture, WKY
BMDMs were replated in six-well plates (1x106 cells per
well) in DMEM (Invitrogen) overnight and transfected
for 48 hours with siGENOME SMARTpool for Jund
(100 nM, Dharmacon) or siGENOME non-targeting
siRNA pool as the scrambled control siRNA using
Dharmafect 1 (1:50, Dharmacon) as a transfection
reagent in OPTIMEM medium (Invitrogen). The siRNA
sequences used in the siGENOME SMARTpool for Jund
are listed in Additional file 2: Table S7. siRNA knock-
down was confirmed with quantitative PCR (detailed
below) and Western blotting (Figure 1).
RNA extraction and microarray preparation
Total RNA was extracted using the TRIzol method and
purified using RNeasy Plus spin columns (Qiagen).
100ng of RNA was amplified, labelled and hybridised to
Rat Gene 1.0 ST arrays (Affymetrix, Santa Clara, CA,
USA) using the Ambion WT Expression Kit (Life
Technologies) as per manufacturer’s instructions. For
timecourse expression analysis, four BMDM prepara-
tions from four biological replicates were used for each
timepoint and condition. For siRNA expression analysis,
four BMDM preparations from at least two biological
replicates were used for each timepoint and condition.
The microarray data is available in MIAME-compliant
(minimum information about a microarray experiment)format at the Array Express database (http://www.ebi.ac.
uk/arrayexpress) under accession code E-MEXP-3469.
Microarray data analysis
CEL intensity files were produced using GeneChip
Operating Software version 1.4 (Affymetrix) and quality
tested using the Affymetrix Expression Console v1.1.2.
All 32 files in the timecourse data set and 16 files in the
siRNA dataset were suitable for further analysis. Probe-
level data was normalised using robust multichip average
(RMA) [48,49]. A custom definition file was created
using up-to-date probe information [50] and filtered to
exclude probes containing the 2,520,602 single nucleo-
tide polymorphisms present between the WKY and LEW
genomes (Santosh Atanur, MRC Clinical sciences centre,
personal communication). The moderated T test with
40,000 permutations implemented in Statistical Analysis
of Microarrays (SAM) version 3.0 was used to identify
differentially expressed genes at an FDR threshold of 5%
and timecourse analysis was performed using EDGE
with 40,000 permutations and a 5% FDR threshold [51].
Hierarchical clustering analysis was performed using
MultiExperiment Viewer (MeV) v4.8 [52,53] with the
Euclidean distance measure. Gene ontology analysis was
carried out using the functional annotation tools within
DAVID, the Database for Annotation, Visualisation and
Integrated Discovery v6.7 [54,55].
Quantitative PCR
All qPCRs were performed with an ABI 7900 Sequence
Detection System (Applied Biosystems, Warrington,
UK). A two-step protocol was used as previously
described [56] beginning with cDNA synthesis with
iScript select (Bio-Rad) followed by PCR using SYBR
Green Jumpstart Taq Ready Mix (Sigma). A total of
10ng of cDNA per sample was used. All samples were
amplified using a set of 4 biological replicates with three
technical replicates used per sample in the PCR.
Sequence detection software (SDS) version (Applied
Biosystems) was used to obtain the Ct values. Results
were analysed using the comparative Ct method and
each sample was normalised to the reference gene Hprt,
to account for any cDNA loading differences. The pri-
mer sequences used for the qRT-PCR validation of
microarray data are listed in Additional file 2: Table S8.
Chromatin immunoprecipitation (ChIP)
BMDMs were left in the basal condition or stimulated
for 2 hours with 100ng/ml LPS. Cells were fixed for 10
minutes with 1% formaldehyde and ChIP performed
using ChIP-IT Express as per manufacturer’s instruc-
tions with some modifications. Sonication was carried
out using Covaris S2 (Woburn, Massachusetts, USA) in
a volume of 300μl sonication buffer with the following
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cycle length 30 s for 28 to 30 cycles dependant on cell
count. The ChIP lysate was immunoprecipitated using 2
μg of JunD antibody (Santa Cruz sc74-X) or negative
IgG control (sc-2026) overnight. Cross links in the
immunoprecipitated chromatin and control input chro-
matin were reversed by heating the samples at 65°C for
5 hours followed by proteinase K digestion for 1 hour.
Samples were purified using Qiagen MinElute columns
as per manufacturer’s instructions prior to downstream
analysis.
High throughput sequencing
Single read library preparation and high throughput sin-
gle read sequencing for 36 cycles was carried out on an
Illumina Genome Analyser IIx according to the manufac-
turer’s protocols (Illumina) with some modifications. Each
immunoprecipitated sample for library preparation was
the product of five separate technical replicates of immu-
noprecipitation pooled together and purified using Qiagen
MinElute columns and quantified using the hsDNA Qubit
assay (Invitrogen, Life Technologies, California, USA). A
1:20 dilution of Illumina adaptors was used at the adaptor
ligation step to avoid adaptor dimer formation and a 1:2
primer dilution used to prevent dimerization during
the PCR amplification stage. The samples were quanti-
fied using the hsDNA Qubit assay (Invitrogen, Life
Technologies, California, USA) and the size range ana-
lysed using a HS DNA chip on a 2100 Bioanalyser
(Agilent Technologies, West Lothian, UK) prior to sub-
mission for qPCR analysis and cluster generation and
sequencing by the CSC/IC Genome Core facility.
qPCR of ChIP enriched DNA
Immunoprecipitated DNA fragments were analysed by
real-time PCR. Primers used are listed in Additional file
2: Table S9. All samples were amplified using a set of 3
biological replicates with three technical replicates used
per sample. After an initial denaturation step of 94°C for
2mins, the samples were cycled 40 times at 94°C for 15s,
60°C for 1 min and 72°C for 1 min with data collection
performed during the 72°C elongation step. Sequence
detection software (SDS) version 2.3 (Applied Biosys-
tems) was used to obtain the Ct values and each sample
was analysed with reference to Ct values for matched
control ‘Input’ non-immunoprecipitated chromatin. A
standard curve of 1:5 dilutions of Input DNA was used
to calculate the % Input level of the transcription factor
binding at the investigated locus. The standard curve
was constructed from the Input DNA sample for the ap-
propriate strain and condition and analysed within the
SDS software v2.3. For each test gene the % Input levels
were then determined using %total = 2ΔCt × (% of input
sample used) where Δ = Ct (Input) - Ct (sample). Foldchange over IgG was expressed using 2-ΔCt where
ΔCt= ΔCtJund – ΔCtIgG.
ChIP-Seq data analysis
Sequencing of the ChIP-Seq libraries was carried out on
the high throughput Illumina Genome Analyzer II. Ini-
tial data processing was performed using Illumina Real
Time Analysis (RTA) v1.6.32 software (equivalent to Illu-
mina Consensus Assessment of Sequence and Variation,
CASAVA 1.6) with default filter and quality settings.
Quality filtered reads were then realigned to the refer-
ence rat genome (RGSC3.4) using the Burrows Wheeler
Alignment tool v0.5.9 (BWA) [57]. Read ends were
trimmed if Phred-scaled base quality scores dropped
below 20. Reads that uniquely mapped to the reference
genome were used to detect areas of enrichment with
BayesPeak v1.1.3 [22,23] using a posterior probability
threshold of 0.9. A stringent posterior probability thresh-
old of 0.9 was used to filter all bins passing the threshold
to form the final contiguous peak regions to produce a
more accurate reflection of true peak calls. An over
fitting diagnostic was performed using λ1 < 0.7 and score
< -2.25 to filter out regions which showed no enrich-
ment but had a high enough background for the algo-
rithm to call peaks in. Peak regions were annotated
using the gene intervals annotator (GIN) implemented
in CARPET using a gene priority approach to give the
associated transcript I.D., the associated gene feature
and the distance of the peak to the nearest transcrip-
tional start site [58]. HOMER was used to predict motif
occurrence within peaks [32,59] with default settings for
a maximum motif length of 12 base pairs. The outputs
of the peak calling algorithms were visualised in the
Integrative Genomics Viewer [60] using custom WIG
files generated from the output data generated by
BayesPeak. The latter were generated by extending each
mapped read by 200 bp and then by using 10 bp bins
the overlapping tag count was generated.
Integrated data analysis and identification of primary
JunD targets
JunD gene expression patterns in WKY and WKY.
LCrgn2 BMDMs over the LPS time course were used for
Spearman correlation analysis with the rest of the tran-
scripts on the microarrays (P < 0.001 cut off ). In order
to integrate the three different datasets, the list of sig-
nificantly correlated set of transcripts was filtered and
annotated according to two criteria: significant differen-
tial expression following Jund siRNA knockdown (both
basal and after LPS stimulation) and the presence of the
JunD ChIP-Seq peaks in WKY BMDMs (both basal and
after LPS stimulation). Two separate networks (basal
and LPS) were built with Cytoscape version 2.8.3 show-
ing primary JunD targets.
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detection of IL-1β by Western Blot and ELISA
Glomeruli were isolated as previously described [13].
After 48 hours of incubation at 37°C, nephritic glomeruli
supernatants were collected and stored at -20°C for IL-
1β sandwich ELISA analysis. For IL-1β detection in
BMDMs by Western Blotting, cells were primed with
LPS (1 μg/ml, 3hours) and stimulated with ATP (5 mM)
for 30 minutes. BMDMs were then scraped and both
cells and supernatant were collected, filtered using Ami-
con ultra centrifugal filters for protein purification and
concentration (10 kDa cut-off, Millipore, UK) and the
concentrated samples were diluted with 5× sample buf-
fer containing 200 mM Tris-HCl, 6% SDS, 2mM EDTA,
4% 2- Mercaptoethanol, 10% glycerol and boiled for
10 minutes. The samples were then resolved by
SDS polyacrylamide gel electrophoresis (PAGE) and
transferred to an Immobilon-P Transfer Membrane
(Millipore). Rabbit polyclonal anti IL-1β (New England
BioLabs, UK) was used to detect the mature IL-1β. To
assess secreted IL-1β in BMDMs and nephritic glom-
eruli, cell supernatants were subjected to sandwich
ELISA and secreted IL-1β amounts were determined
using a standard curve with rat recombinant IL-1β
according to manufacturer’s instructions (R and D
Systems).
For the confirmation of siRNA knockdown of Jund,
WKY BMDMs were plated into six-well plates at a
density of 1 × 106 cells per well and treated with Jund
specific siRNA or a scrambled oligonucleotide for 48
hours before total protein was extracted for Western
Blot analysis using the above technique. For JunD detec-
tion a specific rabbit polyclonal anti-Jund antibody from
Santa Cruz Biotechnology (USA) was used. This blot is
representative of 4 different experiments performed with
4 biological replicates.
Additional files
Additional file 1: Figure S1. Genome-wide expression analysis in basal
and LPS stimulated BMDMs. Genome wide expression analysis by
microarrays was performed in BMDMs transfected with rat Jund or
scrambled control siRNA for the unstimulated condition (A) or following
eight hours of LPS stimulation (B) in WKY BMDMs and over an eight hour
time course of LPS stimulation in WKY and WKY.LCrgn2 BMDMs (C). Heat
maps of hierarchically clustered significantly differentially expressed
genes (<5% FDR threshold) are displayed. All experiments were
performed in 4 biological replicates for each strain or siRNA transfected.
Figure S2. Validation of microarray data between WKY and WKY.LCrgn2
BMDMs over an eight hour LPS stimulation timecourse. Validation of
microarray data by qRT-PCR. Samples were amplified using a set of four
biological replicates with three technical replicates per sample. Relative
gene expression was measured by qRT-PCR and normalised with Hprt for
WKY and WKY.LCrgn2 BMDMs. *P<0.05; **P<0.01;***P<0.001 statistically
significantly different to WKY using a two way ANOVA to compare the
overall timecourse with Bonferonni’s post-tests to compare individual
time points. Figure S3. ChIP-Seq peak validations by ChIP-qPCR. ChIP-
Seq peaks identified at a posterior probability threshold of 0.9 for basalWKY BMDMs were validated by qPCR (A) and for LPS stimulated WKY
BMDMs (B) and WKY.LCrgn2 BMDMs peaks (C). Samples were amplified
using a set of biological triplicates with three technical replicates per
sample. Results expressed as mean fold change over IgG. **P<0.01,
*P<0.05, ns; non-significant using a paired t-test (one-tailed) to compare
whether % input for the JunD ChIP qPCR was significantly different to %
input for IgG. Figure S4. Il1b and Prkca confirmed as primary JunD
targets by qPCR validation. The aligned reads comprising peak passing
the posterior probability threshold of 0.9 for each JunD-bound gene in
the WKY strain in the basal state for l1b (A) and the LPS stimulated state
for Prkca (B) are shown in genome browser views along with the peak in
the WKY.LCrgn2 strain. Samples from WKY and WKY.LCrgn2 strains were
amplified using three biological replicates with three technical replicates
per sample. Results expressed as mean fold change over IgG. *P<0.05;
**P<0.01; using a one-tailed unpaired t-test to detect statistically
significant differences between the strain and condition pairs. Error bars
represent standard error of the mean. Figure S5. Integrative analysis
identifies the transcription factor Bcl2l11 as a primary JunD target. Jund
microarray-determined expression patterns in WKY and WKY.LCrgn2
BMDMs over an eight hour LPS timecourse using four biological
replicates per strain were used for Spearman correlation analysis (A) with
the rest of the transcripts on the microarrays. The expression of Bcl2l11
(B) was significantly correlated to the Jund expression pattern (Spearman
correlation 0.9, corrected p-value=8.6x10-5). Significant differential
expression of the gene was seen following siRNA knockdown of Jund (C).
Fold changes are of control siRNA versus Jund siRNA expression. The
positive fold change indicates higher expression in BMDMs transfected
with scrambled control siRNA i.e. with a higher level of Jund expression
compared to Jund siRNA. Abbreviations: Chr.; chromosome, FDR: false
discovery rate. Three JunD binding events were identified at a posterior
probability threshold of 0.9 in LPS stimulated WKY BMDMs (D) located in
the gene promoter and second intron.
Additional file 2: Table S1. Validation of differentially expressed genes
identified by siRNA microarray data analysis with quantitative PCR. Table
S2. Sequencing and mapping statistics for ChIP-Seq in WKY and WKY.
LCrgn2 BMDMs. Table S3. Gene ontology analysis of JunD-bound genes
in basal WKY BMDMs. Table S4. Gene ontology analysis of JunD-bound
genes in basal WKY.LCrgn2 BMDMs. Table S5. Gene ontology analysis of
JunD-bound genes in LPS stimulated WKY.LCrgn2 BMDMs. Table S6.
Gene ontology analysis of JunD-bound genes in LPS stimulated WKY
BMDMs. Table S7. Sequences of the four individual siRNAs that comprise
siGENOME SMARTpool M-092127-00-0010 (Dharmacon). Table S8. Primer
sequences used for qRT-PCR validation of microarray data. Table S9.
Primer sequences used for qPCR validation of ChIP-Seq data.
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